| [1] |
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98.
|
| [2] |
Shen X, Vaidya A, Wu S, et al. The diabetes epidemic in China: an integrated review of national surveys[J]. Endocr Pract, 2016, 22(9): 1119-1129.
|
| [3] |
Sztanek F, Molnárné Molnár á, Balogh Z. The role of oxidative stress in the development of diabetic neuropathy[J]. Orv Hetil, 2016, 157(49): 1939-1946.
|
| [4] |
Ferland-McCollough D, Slater S, Richard J, et al. Pericytes, an overlooked player in vascular pathobiology[J]. Pharmacol Ther, 2017, 171: 30-42.
|
| [5] |
施丽丽，任明山，吴元洁,等.线粒体分裂蛋白Drp-1参与糖尿病周围神经病发病的机制[J].中华医学杂志, 2012, 92(21): 1502-1504.
|
| [6] |
Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives[J]. Oxid Med Cell Longev, 2013, 2013: 168039.
|
| [7] |
de la Hoz CL, Cheng C, Fernyhough P, et al. A model of chronic diabetic polyneuropathy: benefits from intranasal insulin are modified by sex and RAGE deletion[J]. Am J Physiol Endocrinol Metab, 2017, 312(5): E407-E419.
|
| [8] |
Saleh A, Smith DR, Tessler L, et al. Receptor for advanced glycation end-product（sRAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons[J]. Exp Neurol, 2013, 249: 149-159.
|
| [9] |
Jamwal S, Sharma S. Vascular endothelium dysfunction: a conservative target in metabolic disorders[J]. Inflamm Res, 2018, 67(5): 391-405.
|
| [10] |
Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome[J]. J Diabetes Investig, 2017, 8(5): 646-655.
|
| [11] |
施丽丽，任明山，吴元洁.糖尿病周围神经病变与氧化应激研究现状[J].安徽医科大学学报, 2012, 47(1): 94-96.
|
| [12] |
秦宏超，张真稳. 2型糖尿病周围神经病变患者外周血CD4+调节性T细胞与25-(OH)D3的关系及其意义[J].中国现代医学杂志, 2018, 28(18): 45-49.
|
| [13] |
董荣芳，张铭，郑丹枫,等.糖尿病周围神经病的病理学研究[J].诊断病理学杂志, 2015, 22(3): 133-138.
|
| [14] |
Rachana KS, Manu MS, Advirao GM. Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy[J]. Neurosci Lett, 2016, 629: 110-115.
|
| [15] |
Tang W, Lv Q, Zou JJ, et al. CD8(+) T cell-mediated cytotoxicity toward Schwann cells promotes diabetic peripheral neuropathy[J]. Cell Physiol Biochem, 2013, 32(4): 827-837.
|
| [16] |
Hong J, Tobin NP, Rundqvist H, et al. Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells[J]. J Natl Cancer Inst, 2015, 107(10): pii djv209.
|
| [17] |
Sohail MU, Asmaa A, Haseeb A, et al. Role of the gastrointestinal tract microbiome in the pathophysiology of diabetes mellitus[J]. J Diabetes Res, 2017, 2017: 9631435.
|
| [18] |
Oellgaard J, Winther SA, Hansen TS, et al. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des, 2017, 23(25): 3699-3712.
|
| [19] |
Perez-Matos MC, Morales-Alvarez MC, Mendivil CO. Lipids: a suitable therapeutic target in diabetic neuropathy?[J]. J Diabetes Res, 2017, 2017: 6943851.
|
| [20] |
陈致瑜，刘率男，刘泉,等.阿托伐他汀对糖耐量异常KKAy小鼠胰岛功能的影响及初步机制探讨[J].中国临床药理学杂志, 2014, 30(9): 783-787.
|
| [21] |
张春雪，王燕，郑晓岩,等.二甲双胍对2型糖尿病大鼠胆固醇代谢途径的影响[J].中国老年学杂志, 2017, 37(21): 5238-5240.
|
| [22] |
El-Horany HE, Watany MM, Hagag RY, et al. Expression of LRP1 and CHOP genes associated with peripheral neuropathy in type 2 diabetes mellitus: correlations with nerve conduction studies[J]. Gene, 2019, 702: 114-122.
|
| [23] |
Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury[J]. Prog Neurobiol, 2019, 173: 102-121.
|
| [24] |
Wang X, Chen Q, Yi S, et al. The microRNAs let-7 and miR-9 down-regulate the axon-guidance genes Ntn1 and Dcc during peripheral nerve regeneration[J]. J Biol Chem, 2019, 294(10): 3489-3500.
|
| [25] |
Cheng C, Kobayashi M, Martinez JA, et al. Evidence for epigenetic regulation of gene expression and function in chronic experimental diabetic neuropathy[J]. J Neuropathol Exp Neurol, 2015, 74(8): 804-817.
|
| [26] |
Liu XS, Fan B, Szalad A, et al. MicroRNA-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice[J]. Diabetes, 2017, 66(12): 3111-3121.
|
| [27] |
Zhang Y, Song C, Liu J, et al. Inhibition of miR-25 aggravates diabetic peripheral neuropathy[J]. Neuroreport, 2018, 29(11): 945-953.
|
| [28] |
Chang YS, Kan HW, Hsieh YL. Activating transcription factor 3 modulates protein kinase C epsilon activation in diabetic peripheral neuropathy[J]. J Pain Res, 2019, 12: 317-326.
|
| [29] |
Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial[J]. Lancet, 2010, 376(9739): 419-430.
|
| [30] |
Sahin M, Tutuncu NB, Ertugrul D, et al. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus[J]. J Diabetes Complications, 2007, 21(2): 118-123.
|
| [31] |
王军文，史耐云，陈卫.巨幼细胞贫血伴随维生素B12和(或)叶酸增高的诊断分析[J].国际检验医学杂志, 2013, 34(4): 510.
|
| [32] |
Gupta K, Jain N, Rohatgi A. An observational study of vitamin B12 levels and peripheral neuropathy profile in patients of diabetes mellitus on metformin therapy[J]. Diabetes Metab Syndr, 2018, 12(1): 51-58.
|
| [33] |
Jayabalan B, Low LL. Vitamin B supplementation for diabetic peripheral neuropathy[J]. S Singapore Med J, 2016, 57(2): 55-59.
|
| [34] |
孙丽艳，赵蒙，殷宏宇,等.两种降糖方式对糖尿病周围神经病患者F波的影响及意义[J].中国实验诊断学, 2017, 21(5): 810-813.
|
| [35] |
Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats[J]. J Nutr, 1999, 129(1): 207-213.
|
| [36] |
Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology[J]. Neurology, 2003, 60(6): 898-904.
|
| [37] |
潘映辐.临床诱发电位学[M].第2版.北京:人民卫生出版社, 2000: 165-168.
|
| [38] |
American Diabetes Association. Diabetes advocacy: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S182-S183.
|
| [39] |
Ozaki K, Yamano S, Matsuura T, et al. Insulin-ameliorated peripheral motor neuropathy in spontaneously diabetic WBN/Kob rats[J]. J Vet Med Sci, 2013, 75(10): 1323-1328.
|
| [40] |
Dandona P, Mohanty P, Chaudhuri A, et al. Insulin infusion in acute illness[J]. J Clin Invest, 2005, 115(8): 2069-2072.
|
| [41] |
Koike H, Takahashi M, Ohyama K, et al. Clinicopathologic features of folate-deficiency neuropathy[J]. Neurology, 2015, 84(10): 1026-1033.
|
| [42] |
Mottaghi T, Khorvash F, Maracy M, et al. Effect of folic acid supplementation on nerve conduction velocity in diabetic polyneuropathy patients[J]. Neurol Res, 2019, 41(4): 364-368.
|
| [43] |
Meng X, Maurel P, Lam I, et al. Necl-4/Cadm4 recruits Par-3 to the Schwann cell adaxonal membrane[J]. Glia, 2019, 67(5): 884-895.
|
| [44] |
Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy[J]. J Neurosci Res, 1990, 26(2): 258-267.
|
| [45] |
Cheng HT, Dauch JR, Hayes JM, et al. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes[J]. Neurobiol Dis, 2012, 45(1): 280-287.
|